Breakthrough in Pain Management: FDA Approves First Non-Opioid Drug for Acute Pain
In a significant advancement for pain management, the U.S. Food and Drug Administration (FDA) has approved Suzetrigine (Journavx) 50 mg
Continue ReadingJune 9, 2026
In a significant advancement for pain management, the U.S. Food and Drug Administration (FDA) has approved Suzetrigine (Journavx) 50 mg
Continue Reading